Century Therapeutics, Inc.
USD2.41
+0.09 (+3.88%)
CEO
Brent Pfeiffenberger
IPO Date
2021-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.35
Prev. Close
$2.32
Day Low
$2.17
Day High
$2.50
52W Low
$0.43
52W High
$3.04
Market Cap
$0.21B
Volume
1.85M
| 1,654 |
| $2.23 |
| 15 Jun 2026 | Pfeiffenberger Brent | director, officer: President and CEO | F-InKind | Disposed | 13,849 | $2.24 |
| 15 Jun 2026 | Cowan Chad | Chief Scientific Officer | F-InKind | Disposed | 358 | $2.24 |
| 12 Jun 2026 | Riva Alessandro | director | A-Award | Acquired | 74,000 | $2.24 |
| 12 Jun 2026 | Quimi Daphne | director | A-Award | Acquired | 74,000 | $2.24 |
| 12 Jun 2026 | Murphy Martin Patrick | director | A-Award | Acquired | 74,000 | $2.24 |
| 12 Jun 2026 | Lee Han Myung | director | A-Award | Acquired | 74,000 | $2.24 |
| 12 Jun 2026 | Blackwell Kimberly | director | A-Award | Acquired | 74,000 | $2.24 |
| 9 Jun 2026 | Russotti Gregory | See Remarks | S-Sale | Disposed | 524 | $2.11 |